Team:ESBS-Strasbourg/Results/Characterization
From 2010.igem.org
(Difference between revisions)
Line 540: | Line 540: | ||
<center> | <center> | ||
- | <img src="https://static.igem.org/mediawiki/2010/4/43/ESBS-Strasbourg-Char1.png" width=" | + | <img src="https://static.igem.org/mediawiki/2010/4/43/ESBS-Strasbourg-Char1.png" width="320"> |
<br> | <br> | ||
Chart 1 : Relative specific fluorescence of GFP-, GFP and PIF6-linker-GFP expressing strains. | Chart 1 : Relative specific fluorescence of GFP-, GFP and PIF6-linker-GFP expressing strains. | ||
Line 551: | Line 551: | ||
<br> | <br> | ||
<center> | <center> | ||
- | <img src="https://static.igem.org/mediawiki/2010/9/9f/ESBS_Strasbourg_Figure_2.png" width=" | + | <img src="https://static.igem.org/mediawiki/2010/9/9f/ESBS_Strasbourg_Figure_2.png" width="320"> |
<br> | <br> | ||
- | Figure 2 : Pictures of the SDS gel (on the left), and the corresponding immunoblot (on the right). The immunoblot uses rabbit anti-GFP antibodies. | + | Figure 2 : Pictures of the SDS gel (on the left), and the corresponding immunoblot <br>(on the right). The immunoblot uses rabbit anti-GFP antibodies. |
</center> | </center> | ||
Revision as of 00:56, 28 October 2010
{|
>
... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... |